Description
| Product Name | CAT.No | Size |
| Herpes Simplex Virus-I (HSV-I), IgG | BXE0611A | 96T |
| Herpes Simplex Viru-II (HSV-II), IgG | BXE0613A | 96T |
| Herpes Simplex Virus-II (HSV-II), IgM | BXE0614A | 96T |
| Herpes Simplex Virus (HSV-I/2), IgG | BXE0621A | 96T |
| Herpes Simplex Virus (HSV-I/2), IgM | BXE0622A | 96T |
Product Description
The Biorex Diagnostics Herpes Simplex Virus ELISA kits are highly sensitive and specific qualitative microplate enzyme immunoassays designed for the accurate detection of IgG and IgM antibodies in human serum or plasma. These viruses are common DNA pathogens responsible for oral, genital, and occasionally systemic infections. Early and accurate antibody detection is essential for clinical diagnosis, differentiation of primary and recurrent infections, and monitoring immune response in patients at risk. The assays are particularly valuable in high-risk populations, including pregnant women, immunocompromised individuals, and those presenting with recurrent mucocutaneous lesions.
Key Features
• Qualitative Microplate ELISA – delivers reliable detection of IgG and IgM antibodies.
• Serotype Coverage – identifies both type 1 and type 2 infections.
• High Sensitivity and Specificity – ensures accurate identification of acute or past infections, minimizing false positives and negatives.
• Serum and Plasma Compatibility – validated for routine clinical and laboratory use.
• Reproducible Results – consistent performance across multiple assays.
• Ready-to-Use Components – includes pre-formulated reagents, controls, and standards for streamlined testing.
• Versatile Applications – suitable for clinical diagnostics, prenatal screening, patient monitoring, and research in virology and epidemiology.
The Biorex Diagnostics kits provide a trusted, efficient, and clinically relevant solution for laboratories and healthcare providers worldwide. By enabling dependable antibody detection, the assay supports timely diagnosis, differentiation of viral types, and effective management of recurrent infections. It also facilitates epidemiological research and public health surveillance, contributing to broader understanding and control of these infections. With this reliable testing solution, laboratories can deliver high-quality diagnostics, improve patient care, and support informed clinical and public health decision-making.
Contact Us for more information.